GO:0008470 3-methylbutanoyl-CoA dehydrogenase activity

GO:0008470, 3-methylbutanoyl-CoA dehydrogenase activity, is a molecular function that catalyzes the oxidation of 3-methylbutanoyl-CoA to 3-methyl-(2E)-butenoyl-CoA while reducing oxidized electron-transfer flavoprotein. This reaction is a central step in the mitochondrial degradation of leucine, an essential branched-chain amino acid, and it links acyl-CoA metabolism to the electron-transfer flavoprotein pool used by multiple dehydrogenases. Because the reaction is irreversible under physiological conditions, it commits carbon from leucine toward acetyl-CoA and ketone body production, making it a key control point in energy homeostasis. Researchers study GO:0008470 to understand inherited metabolic disease, mitochondrial redox balance, and the regulation of branched-chain fatty acid synthesis. The enzyme responsible, isovaleryl-CoA dehydrogenase (IVD), is a flavoprotein that requires FAD and transfers electrons to electron-transfer flavoprotein. Mutations that reduce or abolish this activity lead to isovaleric acidemia, a disorder characterized by vomiting, lethargy, and metabolic acidosis after protein-rich meals. Beyond clinical genetics, GO:0008470 is relevant to microbial and plant metabolic engineering because the same activity participates in branched-chain amino acid catabolism and in the production of branched-chain fatty acids. The FadR regulator can derepress the bkd operon, altering the flux through this activity and influencing isoleucine starvation responses. Thus, GO:0008470 sits at the intersection of amino acid catabolism, cofactor metabolism, and metabolic regulation.

In plain terms, GO:0008470 describes the catalytic activity that removes hydrogen from 3-methylbutanoyl-CoA (also called isovaleryl-CoA) and transfers the electrons to oxidized electron-transfer flavoprotein, producing 3-methyl-(2E)-butenoyl-CoA and reduced electron-transfer flavoprotein. The reaction is: 3-methylbutanoyl-CoA + H+ + oxidized [electron-transfer flavoprotein] = 3-methyl-(2E)-butenoyl-CoA + reduced [electron-transfer flavoprotein]. This activity is synonymous with isovaleryl-CoA dehydrogenase activity and 3-methylbutanoyl-CoA:(acceptor) oxidoreductase activity.

GO:0008470 is important because it represents the committed step in leucine catabolism and a major entry point for electrons into the mitochondrial electron-transfer flavoprotein system. Defects in this activity cause isovaleric acidemia, and altered flux through the reaction affects branched-chain fatty acid production and isoleucine availability. Understanding its regulation and catalytic mechanism is therefore essential for metabolic disease research, mitochondrial biology, and metabolic engineering.

The following genes and proteins are directly or indirectly associated with GO:0008470 and its regulation in metabolic pathways.

The activity of GO:0008470 is regulated at multiple levels. The FadR regulator can derepress the bkd operon, leading to elevated production of branched-chain fatty acids and isoleucine starvation, which indirectly affects flux through isovaleryl-CoA dehydrogenase. Additionally, the availability of FAD cofactor and the redox state of the electron-transfer flavoprotein pool influence catalytic turnover. Because the reaction is irreversible, its regulation is critical for maintaining leucine homeostasis and energy balance.

Isovaleric acidemia is an inherited metabolic disorder caused by deficiency of isovaleryl-CoA dehydrogenase activity (GO:0008470). Patients accumulate isovaleric acid and related metabolites, leading to vomiting, lethargy, metabolic acidosis, and in severe cases coma. Newborn screening and dietary management are mainstays of care, and CRISPR models of IVD mutations help dissect disease mechanisms.

Because GO:0008470 feeds electrons into the electron-transfer flavoprotein pool, its dysfunction can impair mitochondrial energy metabolism and contribute to broader metabolic decompensation. Research on FadR and branched-chain fatty acid production highlights how perturbations in this activity affect isoleucine availability and cellular metabolism.

Altered flux through GO:0008470 influences the production of branched-chain fatty acids, which are important in microbial and industrial biotechnology. Derepression of the bkd operon by FadR loss elevates branched-chain fatty acid production and causes isoleucine starvation, linking this activity to metabolic engineering strategies.

Direct measurement of 3-methylbutanoyl-CoA dehydrogenase activity can be performed using spectrophotometric assays that monitor the reduction of electron-transfer flavoprotein or artificial electron acceptors. These assays are essential for confirming loss-of-function in CRISPR knockout models.

Stable isotope tracing with labeled leucine or isovaleryl-CoA can quantify flux through GO:0008470 and downstream pathways. This approach reveals how genetic perturbations alter branched-chain amino acid catabolism.

RNA-seq and proteomics can assess expression changes in IVD, ETFA, ETFB, and related genes following CRISPR editing or FadR manipulation. These methods help identify compensatory pathways and regulatory networks.

Genome-wide CRISPR knockout screens coupled with metabolic phenotyping can identify genes that modify GO:0008470 activity or its downstream effects. Bioinformatics analysis of screening data reveals enriched pathways and candidate regulators.

Researchers studying 3-methylbutanoyl-CoA dehydrogenase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic flux, disease phenotypes, or drug response. EDITGENE provides publication-ready CRISPR cell models and screening services to accelerate this discovery process.

GO:0008470, 3-methylbutanoyl-CoA dehydrogenase activity, is a critical molecular function in leucine catabolism and mitochondrial electron transfer. Its dysfunction causes isovaleric acidemia, and its regulation influences branched-chain fatty acid production and isoleucine homeostasis. CRISPR-based models and multi-omics approaches provide powerful tools to dissect its mechanism and disease relevance. EDITGENE offers comprehensive CRISPR services, including knockout, point-mutation, knock-in, overexpression, and library screening, to support research on GO:0008470 and related metabolic pathways.